CORK, Ireland, Nov. 14, 2017 -- Aquamin, a multi-mineral complex derived 100% from seaweed, was recently researched for its effects of calcium in a new human study that was published in the Journal of Medicinal Food. The study revealed Aquamin as having more bioavailability compared to calcium carbonate.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ed5e8dca-00be-408c-94b9-5c79888669d5
Entitled “Effect of Calcium Derived from Lithothamnion sp. on Markers of Calcium Metabolism in Premenopausal Women,” this study evaluated if botanically derived calcium had a greater influence over calcium metabolism markers compared with a nonplant-derived calcium carbonate supplement or placebo in premenopausal women. The study also showed that Aquamin, or Lithothamnion sp., provides prolonged suppression of serum parathyroid hormone (PTH) concentrations following a meal in premenopausal women. Although additional studies are needed, the study suggests Aquamin may represent an effective means of providing calcium supplementation to individuals at risk of bone loss due to osteoporosis.
“Our ingredient is unique as it is one of the few plant-based sources of calcium with such high levels of the mineral,” said David O’Leary, Commercial Manager of Marigot Ltd., the creators of Aquamin. “This human study further proves the benefits of Aquamin as a unique ingredient helping to support bone health.”
To be effective, calcium supplements must contain readily bioavailable calcium. Many calcium supplements vary widely in their bioavailability and although natural plant sources of calcium are rare, the mineralized remains of the marine red algae known as Aquamin contain large amounts of a highly porous and readily bioavailable calcium. This bioavailability makes Aquamin a versatile ingredient for use in solid and semi-solid food production, in products including baking, cereals and snacks, rice, pasta, noodles, ice cream, instant drinks and more.
Aquamin is exclusively distributed in North America by Stauber Performance Ingredients, Inc. It is derived solely from seaweed harvested off the coast of Iceland under an exclusive license and provides bioactive calcium, magnesium and 72 other trace marine minerals, which can be used in the fortification of food, beverage and supplement products.
For more information regarding Aquamin, visit www.aquamin.com.
About Aquamin
Aquamin is a unique marine multi-mineral complex derived from the Lithothamnion seaweed species. Sustainably harvested under licence off the Northwest coast of Iceland, this truly natural mineral offering has been extensively evaluated in clinical trials and demonstrated proven efficacy in multiple health areas. Today, this material is supported by over 30 scientific peer reviewed publications covering bone, joint and digestive health areas. Marigot’s approach has always been one of innovation based on science and it has pioneered the development of this mineral across nutraceutical supplement and food ingredient markets internationally.
MEDIA CONTACT
Valeria Velasco
310-405-0357
[email protected]


AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Amazon Explores AI Content Marketplace With Media Publishers
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



